An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts

Annals of Vascular Surgery

Volumn 18, Issue 3, 2004, Pages 308-313

  Hardman, S ^a,b   Cope, A ^a,b   Swann, A ^a,b   Bell, P R F ^a,b   Naylor, A R ^a,b   Hayes, P D ^a,b  

^a Leicester Royal Infirmary ^*

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; SILVER;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BLOOD VESSEL GRAFT; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; GRAFT INFECTION; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION;

EID: 2542480019     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-004-0042-5     Document Type: Article

References (19)

1. Hayes PD, Nasim A, London NJL, et al. Rifampicin bonded grafts for the treatment of major aortic graft infection: the Leicester experience. J. Vasc. Surg. 1999;30:92-98.
2. Naylor AR, Hayes PD, Darke S. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur. J. Vasc. Endovasc. Surg. 2001;21:289-294.
3. Chervu A, Moore W, Chvapil M, et al. Efficacy and duration of anti-staphylococcal activity comparing 3 antibiotics bonded to Dacron vascular grafts with a collagen release system. J. Vasc. Surg. 1991;13:897-901.
4. Magnan PE, Seyral P, Raoult D, et al. In vitro anti-staphylococcal activity of collagen-sealed Dacron vascular prosthesis bonded with rifampicin, vancomycin or amikacin. Ann. Vasc. Surg. 1994;8:243-247.
5. Strachan CJL, Newsome SWB, Ashton TR. The clinical use of an antibiotic-bonded graft. Eur. J. Vasc. Surg. 991;5:627-632.
6. Mertens RA, O'Hara PJ, Hertzer NR, et al. (1995) "Surgical management of infra-inguinal arterial prosthetic graft infections: review of a thirty-five year experience" J. Vasc. Surg. 21:782-790.
7. Lorentzen JE, Nielsen OM, Arendrup H, et al. (1985) "Vascualr graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts" Surgery 98:81-86.
8. Edwards WH, Jr, Martin RS, III, Jenkins JM, et al. (1987) "Primary graft infections" J. Vasc. Surg. 6:235-239.
9. Calligaro KD, Veith FJ, Schwartz ML, et al. (1995) "Recommendations for initial antibiotic treatment of extracavitary arterial graft infections" Am. J. Surg. 170:123-125.
10. Speller DC, Johnson AP, James D, et al. Resistance to methicillin and other antibiotics in isolates of S. aureus from blood and CSF, England and Wales, 1989-1995. Lancet 1997;350:323-325.
11. Bandyk DF, Novotney ML, Johnson BL, et al. Use of rifampicin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J. Surg. Res. 2001;95:44-49.
12. Torsello G, Sandman W. Use of antibiotic-bonded grafts in vascular graft infection. Eur. J. Vasc. Endovasc. Surg. 1997;14(Suppl A):84-87.
13. D'Addato M, Curti T, Freyrie A. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: two-year follow-up of a prospective clinical trial. Cardiovasc. Surg. 1996;4:200-204.
14. Braithwaite BD, Davies B, Heather BP, et al. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group. Br. J. Surg. 1998;85:1378-1381.
15. Darouiche RO. Anti-infective efficacy of silver-coated medical prostheses. Clin. Infect. Dis. 1999;29:1371-1377.
16. Schierholz JM, Lucas LJ, Rump A, Pulverer G. Efficacy of silver-coated medical devices. J. Hosp. Infect. 1998;40:257-262.
17. Mc Hugh SL, Merellering RC, Hopkins CC, et al. Salmonella typhimurium resistant to silver nitrate, chloramphenicol and ampicillin. Lancet 1975;1:235-240.
18. Hendry AT, Stewart IO. Silver-resistant Enterobacteriacae from hospital patients. Can. J. Microbiol. 1979;25:915-921.
19. Kinney E, Bandyk D, Seabrook G, et al. Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J. Surg. Res. 1991;50:430-435.